Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates.

Area of Science:

• Biomedical Imaging
• Nanotechnology
• Cell Biology

Background:

• Magnetic Resonance Imaging (MRI) suffers from low sensitivity compared to Positron Emission Tomography (PET).
• Amplification strategies are crucial for specific pathway labeling to improve MRI sensitivity.
• Gadolinium(III) chelates are key contrast agents for MRI, but efficient cellular uptake is challenging.

Purpose of the Study:

• To survey diverse cellular internalization routes for Gadolinium(III) chelates.
• To identify methods for achieving high intracellular concentrations of Gd(III) chelates for MRI visualization.
• To evaluate the potential of various cell labeling strategies for enhancing MRI sensitivity.

Main Methods:

• Review of internalization mechanisms including pinocytosis, phagocytosis, receptor-mediated endocytosis, transporters, and carrier peptides.
• Analysis of Gd(III) chelate entrapment efficiency via different cellular pathways.
• Assessment of required intracellular Gd(III) chelate concentrations (10^7-10^8/cell) for MRI visualization.

Main Results:

• Pinocytosis is effective for labeling cells with prolonged incubation and high Gd-agent concentrations, particularly stem cells.
• Nanoparticles loaded with Gd(III) chelates efficiently label phagocytic cells.
• Receptor-mediated endocytosis, including functionalized chelates and supramolecular systems, offers another internalization route.
• Targeting nutrient transporters in tumor cells and utilizing penetrin-like peptides are promising strategies.

Conclusions:

• Achieving high intracellular Gd(III) chelate concentrations (10^7-10^8/cell) is feasible through various cellular uptake pathways.
• Pinocytosis and nanoparticle-mediated phagocytosis are effective for specific cell types.
• Targeted delivery via transporters and peptides represents a novel approach for cell-specific MRI contrast enhancement.